Cinemark CFO sells 22,082 shares in Rule 10b5-1 trade

Cinemark Holdings executive stock sale disclosed.

Rhea-AI Filing Summary

Cinemark Holdings executive stock sale disclosed. An executive officer of Cinemark Holdings, Inc., serving as EVP and Chief Financial Officer, reported selling 22,082 shares of the company’s common stock on 12/10/2025 at a weighted average price of $24.81 per share. The transaction was coded as a sale and was made under a pre-arranged Rule 10b5-1 trading plan adopted on September 10, 2025, which is designed to allow insiders to sell shares according to a set schedule.

After this transaction, the executive beneficially owns 167,360 shares of Cinemark common stock in direct form. The filing lists no derivative securities transactions, and it is filed by a single reporting person.

Insider Trade Summary

Net Seller: 22,082 shares

Net Sell 1 txn

Insider Thomas Melissa

Role EVP, Chief Financial Officer

Sold 22,082 shs ($548K)

Type	Security	Shares	Price	Value
Sale	Common Stock	22,082	$24.81	$548K

Holdings After Transaction: Common Stock — 167,360 shares (Direct)

Footnotes (2)

1. F1. The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2025.
2. F2. The reported price per share is the weighted average sale price for the shares.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Cinemark Holdings (CNK) report in this Form 4?

A Cinemark Holdings, Inc. executive reported the sale of 22,082 shares of common stock on 12/10/2025 in an open market transaction.

At what price were the Cinemark (CNK) shares sold by the executive?

The reported price per share was a weighted average sale price of $24.81 for the shares sold.

Which Cinemark (CNK) insider sold shares and what is their role?

The reporting person is an officer of Cinemark Holdings, Inc., serving as EVP, Chief Financial Officer, as indicated in the filing.

How many Cinemark (CNK) shares does the executive own after this transaction?

Following the reported sale, the executive beneficially owns 167,360 shares of Cinemark common stock, held directly.

Was the Cinemark (CNK) insider sale made under a Rule 10b5-1 plan?

Yes. The filing states that the sale occurred automatically under a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2025.

Does this Cinemark (CNK) Form 4 report any derivative securities transactions?

No. The table for derivative securities is included but shows no specific derivative transactions reported in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/11/2025 - 04:43 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Thomas Melissa

(Last) (First) (Middle)

3900 DALLAS PARKWAY

(Street)

PLANO TX 75093

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cinemark Holdings, Inc. [ CNK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/10/2025		S		22,082(1)	D	$24.81(2)	167,360	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2025.

2. The reported price per share is the weighted average sale price for the shares.

	/s/ Michael Cavalier attorney-in-fact	12/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.